This transgene expresses Cre recombinase and beta-galactosidase under the control of the human glial fibrillary acidic (GFAP) promoter. This transgene is expressed in astrocytes by embryonic day 14.5. Two lines 1 and 8 were analyzed further for cre activity and expression. Both gave identical results, with data for line 8 presented in the reference.